189 related articles for article (PubMed ID: 9215596)
1. Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade.
Santucci V; Gueudet C; Steinberg R; Le Fur G; Soubrié P
Synapse; 1997 Aug; 26(4):370-80. PubMed ID: 9215596
[TBL] [Abstract][Full Text] [Related]
2. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A
Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY262691: mediation through feedback pathways from forebrain sites.
Rasmussen K; Howbert JJ; Stockton ME
Synapse; 1993 Oct; 15(2):95-103. PubMed ID: 8259526
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
[TBL] [Abstract][Full Text] [Related]
6. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
Meltzer LT; Christoffersen CL; Heffner TG; Freeman AS; Chiodo LA
J Pharmacol Exp Ther; 1989 Oct; 251(1):123-30. PubMed ID: 2571714
[TBL] [Abstract][Full Text] [Related]
7. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Nakamura K; Suzuki K; McCreary AC; Ashby CR
Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
Wachtel SR; White FJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
[TBL] [Abstract][Full Text] [Related]
9. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin modulation of acetylcholine, GABA, and aspartate release from rat prefrontal cortex studied in vivo with microdialysis.
Petkova-Kirova P; Rakovska A; Della Corte L; Zaekova G; Radomirov R; Mayer A
Brain Res Bull; 2008 Sep; 77(2-3):129-35. PubMed ID: 18721670
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission.
Yan QS; Zheng SZ; Feng MJ; Yan SE
Brain Res; 2005 Oct; 1060(1-2):126-37. PubMed ID: 16212943
[TBL] [Abstract][Full Text] [Related]
12. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
13. Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems.
Azzi M; Betancur C; Sillaber I; Spanagel R; Rostène W; Bérod A
J Neurochem; 1998 Sep; 71(3):1158-67. PubMed ID: 9721741
[TBL] [Abstract][Full Text] [Related]
14. Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
Brun P; Leonetti M; Sotty F; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
J Neurochem; 2001 Jun; 77(6):1542-52. PubMed ID: 11413237
[TBL] [Abstract][Full Text] [Related]
15. [Neurotensin receptor antagonists and therapeutical perspectives].
Gully D; Maffrand JP; Soubrié P; Rostène W; Kitabgi P; Le Fur G
Therapie; 1995; 50(1):5-7. PubMed ID: 7754478
[TBL] [Abstract][Full Text] [Related]
16. Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens.
Brun P; Steinberg R; Le Fur G; Soubrié P
J Neurochem; 1995 May; 64(5):2073-9. PubMed ID: 7722490
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor.
Chen L; Yung KK; Yung WH
Neuroscience; 2004; 125(4):853-9. PubMed ID: 15120846
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP
J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
[TBL] [Abstract][Full Text] [Related]
19. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.
Gronier B; Rasmussen K
Br J Pharmacol; 1998 Jun; 124(3):455-64. PubMed ID: 9647468
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent pain-facilitatory and -inhibitory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: influence on the antinociceptive effect of morphine.
Smith DJ; Hawranko AA; Monroe PJ; Gully D; Urban MO; Craig CR; Smith JP; Smith DL
J Pharmacol Exp Ther; 1997 Aug; 282(2):899-908. PubMed ID: 9262357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
